BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 15194174)

  • 21. Ion channels in pulmonary arterial hypertension.
    Mandegar M; Remillard CV; Yuan JX
    Prog Cardiovasc Dis; 2002; 45(2):81-114. PubMed ID: 12411972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary arterial hypertension.
    Murali S
    Curr Opin Crit Care; 2006 Jun; 12(3):228-34. PubMed ID: 16672782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
    Tuder RM; Groves B; Badesch DB; Voelkel NF
    Am J Pathol; 1994 Feb; 144(2):275-85. PubMed ID: 7508683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.
    Giaid A; Yanagisawa M; Langleben D; Michel RP; Levy R; Shennib H; Kimura S; Masaki T; Duguid WP; Stewart DJ
    N Engl J Med; 1993 Jun; 328(24):1732-9. PubMed ID: 8497283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension.
    Voelkel NF; Tuder RM
    Pulm Pharmacol Ther; 1997; 10(5-6):231-41. PubMed ID: 9778486
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".
    Archer S; Rich S
    Circulation; 2000 Nov; 102(22):2781-91. PubMed ID: 11094047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From functional to genetic studies of a candidate gene for pulmonary hypertension: Any point?
    Eddahibi S; Adnot S
    Am J Respir Crit Care Med; 2006 Apr; 173(7):693-4. PubMed ID: 16556698
    [No Abstract]   [Full Text] [Related]  

  • 28. Cellular and molecular basis of pulmonary arterial hypertension.
    Morrell NW; Adnot S; Archer SL; Dupuis J; Lloyd Jones P; MacLean MR; McMurtry IF; Stenmark KR; Thistlethwaite PA; Weissmann N; Yuan JX; Weir EK
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S20-S31. PubMed ID: 19555855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension.
    Botney MD
    Am J Respir Crit Care Med; 1999 Feb; 159(2):361-4. PubMed ID: 9927344
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms of abnormal vasoreactivity in persistent pulmonary hypertension of the newborn infant.
    Abman SH; Ivy DD; Ziegler JW; Kinsella JP
    J Perinatol; 1996; 16(2 Pt 2 Su):S18-23. PubMed ID: 8732544
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased pulmonary blood flow produces endothelial cell dysfunction in neonatal swine.
    Vitvitsky EV; Griffin JP; Collins MH; Spray TL; Gaynor JW
    Ann Thorac Surg; 1998 Oct; 66(4):1372-7. PubMed ID: 9800835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.
    Jeffery TK; Morrell NW
    Prog Cardiovasc Dis; 2002; 45(3):173-202. PubMed ID: 12525995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels.
    Michelakis ED; Weir EK
    Clin Chest Med; 2001 Sep; 22(3):419-32. PubMed ID: 11590838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disorders of thrombocyte function and/or endothelial cell damage as a cause of primary pulmonary hypertension?].
    Mlczoch J
    Herz; 1986 Aug; 11(4):191-6. PubMed ID: 3530927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathobiology of pulmonary hypertension. Endothelium.
    Tuder RM; Cool CD; Yeager M; Taraseviciene-Stewart L; Bull TM; Voelkel NF
    Clin Chest Med; 2001 Sep; 22(3):405-18. PubMed ID: 11590837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide.
    Aytekin M; Aulak KS; Haserodt S; Chakravarti R; Cody J; Minai OA; Dweik RA
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L512-20. PubMed ID: 22246002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary hypertension and cor pulmonale.
    Auger WR
    Curr Opin Pulm Med; 1995 Jul; 1(4):303-12. PubMed ID: 9363069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension.
    Jeffery TK; Wanstall JC
    Pharmacol Ther; 2001 Oct; 92(1):1-20. PubMed ID: 11750034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology and aspects of pathogenesis in pulmonary arterial hypertension.
    Dorfmüller P; Humbert M; Capron F; Müller KM
    Sarcoidosis Vasc Diffuse Lung Dis; 2003 Mar; 20(1):9-19. PubMed ID: 12737275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cellular mechanisms regulating vascular function and structure--implications in the pathogenesis of hypertension.
    Touyz RM
    Can J Cardiol; 2000 Sep; 16(9):1137-46. PubMed ID: 11021957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.